Analysis on the use of narcotic drugs for inpatients
10.12206/j.issn.1006-0111.202004095
- VernacularTitle:我院住院患者麻醉药品使用情况分析
- Author:
Baichen HAN
1
;
Meiling ZHANG
1
;
Ying ZHANG
1
;
Yang YANG
1
Author Information
1. Department of Pharmacy, Changhai Hospital Affiliated to Naval Medical University, Shanghai 200433, China.
- Keywords:
narcotic drugs;
dose form;
pethidine;
rational drug use
- From:
Journal of Pharmaceutical Practice
2020;38(4):379-382
- CountryChina
- Language:Chinese
-
Abstract:
Objective To investigate and analyze the inpatient use of narcotic drugs, provide reference for clinical norms and rational use of narcotic drugs. Methods The narcotic prescription number, usage and cost were analyzed statistically. The inpatient narcotic use was analyzed by screening the dose form, indication, and dosage. Results The injections topped the list of narcotic prescriptions from year 2016 to 2019 with 15 820 (61.4%), 15 813 (61.5%), 16 682 (64.7%) and 17 293 (71.5%) prescriptions respectively. The oral and topical narcotic drugs were less prescribed. Although pethidine hydrochloride injection prescriptions decreased year by year, it still topped in the narcotic use with 8 009 (31.1%), 7 707 (30.0%), 7 151 (27.7%) and 6 844 (28.3%) prescriptions each year. Pethidine hydrochloride injection was mostly used for patients with cancer and chronic pancreatitis. Conclusion Doctors preferred to use injectable narcotics for patients with moderate to severe pain. Improper use of narcotic drugs was noticed, such as unsuitable choice of dose form, inappropriate use of pethidine hydrochloride injection, etc. Pharmacists should keep vigilant in prescription review and medication intervention for narcotic drugs to improve the standardization and rational use of narcotics.
